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This study investigated and analyzed the Korean and international status of radioactive waste 
management for medical linear accelerators (linacs) and proceed prior research to suggest radiation 
safety regulations and guidelines for the safe use of radiation. We analyzed the number of linacs 
installed in the radiation oncology departments of 103 institutions. In addition, we analyzed the 
procedures and standards for disposal in Korea and foreign countries. For foreign countries, we 
analyzed the status based on reports from the United States, Japan, Europe, and Canada. A total of 
182 linacs are installed in Korea and 95% of them use more than 10 MV of energy. In Korea, 
standards for managing radioactive waste from a linac, disposal procedures, and clearance criteria 
have yet to be established. Therefore, radioactive waste is disposed of in different ways depending 
on the hospitals where they originate. Japan, the US, and Canada have recommended clearance 
levels and procedures for linacs. Other countries have provided management guidelines for 
research or large-scale accelerators, but not for medical purposes. In this study, we investigated 
the management of radioactive waste from medical linacs in Korea and abroad. Several foreign 
countries have suggested a clearance level and criteria for disposing of waste storage drums. For 
the safe management of medical linacs, it is necessary to establish safety management 
regulations. In Korea, standards for disposal, such as radiation or dose limits, are required for 
medical linacs. A system for clearance when disposing at a medical institution should be created.
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Introduction
The radiotherapy device industry is growing as part of 
the development of radiotherapy technology. In particular, 
radiation treatment technology that uses high-energy ra-
diation of 6 to 15 MV or more is rapidly being incorporated 
by medical institutions; interest in the use of safe radia-
tion therapy devices is also increasing while improving the 
quality of life of patients treated with high-precision radia-
tion. Currently, most institutions in Korea and abroad use 
an 8–15 MV high-energy linear accelerator (linac), so using 
technology based on preceding radiation safety regulations 
is crucial. In Korea, however, it is difficult to systematically 
manage radioactive waste because of the absence of guide-
lines for disposal or replacement of linacs due to aging or 
failed parts.




Progress in Medical Physics   Vol. 31, No. 4, December 2020 195
www.ksmp.or.kr
NCRP (National Council on Radiation Protection and 
Measurement) 79 and IAEA (International Atomic Energy 
Agency) TECDOC 1183 outlined the need to manage ra-
dioactive waste from internal components, such as a target, 
collimator, flattening filter, and ion chamber when disman-
tling a linac. The IAEA TECDOC 1183 showed that a pos-
sibility exists for the radiation of surrounding substances 
when using an accelerator of 10 MV or more and that the 
head parts are activated during the disassembly of an 
linac; therefore, an evaluation of the activation should be 
conducted [1]. According to NCRP 79, when energy of 10 
MV or more is used, a radiation evaluation is required and 
activation occurs in the head parts, such as the target, col-
limator, and flattening filter [2]. NCRP 151 states that when 
a high-energy accelerator of 10 MV or more is used, radio-
nuclides may be generated by the radiation of neutrons 
and gamma rays from the components of linac, which may 
result in exposure to patients and staff [3]. 
According to data from the Workshop for Improving 
Safety Management in the Medical Field, a total of 11 lin-
acs were replaced from 2013 to 2017 and a total of 17 linacs 
were discarded [4]. On average, two or more linacs are re-
placed or discarded every year, although the relevant regu-
lations and standards have yet to be established.
In accordance with the Nuclear Safety Commission No-
tice No. 2017–65, standards and clearance levels are stipu-
lated according to the allowable concentration of nuclides 
[5]. However, information on radionuclides generated 
during the process of discarding a linac is limited and vari-
ables, such as the number of patients, treatment methods, 
and treatment device models, change depending on the fa-
cility. Due to a lack of standardized regulations for disposal 
or management, an urgent need exists for the development 
of a management plan for the disposal of radioactive waste.
The operational period of a linac is typically 10 to 15 
years and linacs are replaced or discarded for various rea-
sons, such as aging parts, failure of major parts, and the 
introduction of new treatment devices. When disposing of 
equipment, it is recommended to report this to the Korea 
Institute of Nuclear Safety (KINS) and dispose of or store 
waste when considering the activation. In addition, dis-
carding the linac after measurements have been taken and 
clearance is possible is recommended, although standards 
and procedures (e.g., clearance and consignment disposal) 
have yet to be established. In this study, to establish a basis 
for safety management procedures and regulations when 
replacing or discarding a medical linac, we analyzed cur-
rent practices for managing radioactive waste from medical 
linacs in Korea and other countries.
Status of Medical Linac Radioactive Waste 
Management in Korea
1. Status of medical linacs in Korea
There are 103 hospitals using a linac in Korea, with a to-
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Fig. 1. Number of linear accelerators (linacs) installed dome-
stically (1992–2020).
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according to the year they were installed from 1992 to 2020. 
A total of 66 linacs were installed between 1992 and 2010. 
Considering that the average life of a linac is 10 to 15 years, 
it is expected that their replacement or disposal owing to 
new installations will rapidly increase.
Fig. 2 shows an analysis of the energy used by installed 
linac equipment. Approximately 95% of linacs use more 
than 10–15 MV of energy and more than 95% of linacs use 
this energy to generate an activation product.
2. Current state of disposal of medical linacs in 
Korea
In Korea, no legally stipulated procedures or standards 
exist for linac disposal and thus disposal methods vary in 
different hospitals. The Nuclear Safety and Security Com-
mission of Korea and the Korea Radioactive Waste Agency 
create regulations for the disposal of radioactive materials, 
such as radioisotopes.
Some hospitals store the entire head part of the radioac-
tive linac in a radioactive waste storage facility at the hospi-
tal after detachment. In addition, several parts are used as 
education-assistive tools or are collected by replacement 
companies without evaluation of the radioactive concen-
tration/contamination when replaced.
Some hospitals have applied a clearance or consignment 
disposal process by hiring a disposal company. The related 
disposal procedures are shown in Fig. 3, which shows that 
after shutdown of a linac, the equipment should be dis-
mantled immediately or within one to two months after 
shutdown. When the linac is disposed, the disposal com-
pany measures the surface dose rate for each component 
by using a survey meter. When relocating or disposing of 
equipment through a company, these processes proceed 
without measuring the dose rate. Waste with a dose rate 
below the level of the background level of the dose rate 
(radiation) is disposed of as general waste and waste above 
the background is stored in the radioisotope waste storage 
facility of the hospital.
Currently, when disposing of a medical linac with a 
disposal company in Korea, a document on measures for 
disposing of a radiation-generating device is provided, as 
shown in Fig. 4. The document includes information on the 
disposal equipment, removal date, measures taken, results 
of the dose rate measurement, information on the detector 
used, and the calibration date. In addition, as shown on the 
Fig. 4b, the dose rate is measured using a survey meter for 
each component of the discarded linac. When dismantling, 
the surface dose is measured and recorded for each major 
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Fig. 3. Linear accelerator (linac) disposal and disposal procedure in Korea.
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Radioactive Waste Management Status of 
Medical Linacs in Other Countries
1.  Status of linac radioactive waste management 
in the United States
1) Management of radioactive waste
The US Department of Energy (DOE) published techni-
cal standards in 2016 to support the control, clearance, and 
release of personal property (materials, equipment, and 
items) from an accelerator, accelerator facilities, and mod-
ules. In this report, based on DOE Directive Order 458.1 
and ANSI N13.12-2013, regulations regarding the require-
ments for radiological protection of the air and environ-
ment are described [6–8]. The DOE report is based on large 
accelerators, such as the SLAC (Stanford Linear Accelerator 
Center), and suggests clearance standards, process knowl-
edge, and measurement methodology.
The total effective dose limit is set at 0.01 mSv/y for the 
disposal of properties with residual radioactivity as stipu-
a b
Fig. 4. Documents for measuring 
the disposal of radiation-generating 
device (a) and measurement of dose 
rate by parts of medical linac (b).
Table 1. Contents of general program documents and documents related to clearance
General program documentation Additional documents for clearance
Related regulations and standards
Clearance and release/dismantling programs 
Accelerator and facility parameters and operating history
Surface and volume radioactivity evaluation
Procedures and records of radiation area classification, 
measurement method, and location
Criteria for clearance
A description of the concept and measurement of proxy 
radionuclides and difficult to measure nuclides
Clearance measurement procedure for proxy radionuclides
Limits of detection for proxy radionuclides
Procedures and records for instrument calibration and testing
Procedures and records of training and qualifications for conducting 
measurements and using the device
Procedures and records for storage locations on site before release
Plan for discussion with stakeholder
Additional process knowledge used in the measurement process 
during clearance (beam parameters and operating conditions, 
materials, etc.)
Records of past measurement of parts to be ejected
Description of facility and component
Radiation irradiation report: measurement conditions and results, 
including date and place of measurement, model and serial 
number of the detector, calibration date, background dose rate, 
inspection report, and measurement conditions and results
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lated in O 458.1 and 10 CFR Part 835.1101. The DOE report 
presented the screening level and dose limit for surface 
and volumetric activity based on 0.01 mSv/y [9].
The DOE report recommends that process knowledge 
is used to determine whether radioactivity remains in the 
various parts of a linac during disposal. Process knowledge 
indicates whether a substance can be radiated or con-
taminated and classified as general knowledge or specific 
knowledge. General process knowledge includes informa-
tion that is equally applicable to most accelerator installa-
tions with similar properties or operations, such as beam 
energy and particle types. 
When disposing of a linac, a document should be pro-
duced that contains the contents of its work history, proce-
dures, and measurements, including process knowledge, 
as shown in Table 1.
2) Linac decommissioning and disassembly procedure
Fig. 5 shows the linac disposal process [10]. After the linac 
is turned off, the head part is detached and its multileaf col-
limator (MLC), collimator head, gantry head, and bending 
magnet are discarded. Because the degree of activation var-
ies according to the energy used in the linac, the parts must 
be disassembled and handled only after the recommended 
length of time. Components should not be removed until 
the dose rate is less than 50 μSv/h (5 mrem/h) at a distance 
of 1 ft (30 cm) from the surface of the linac.
•  Accelerators using 10–14 MV X-ray energy: at least 1 
hour after beam shutdown
•  Accelerators operating above 15 MV X-ray energy: a 
longer attenuation period is recommended, typically 
12–24 hours after beam shutdown
The list of hazardous substances and substances that 
should be removed from the linac gantry head, including 
non-radioactive parts, is as follows:
•  Sealed components containing oil that may contain 
printed circuit boards (PCBs) (e.g., capacitors, trans-
formers)
•  PCBs with a surface area of 10 cm2 or larger
• Plastic containing brominated flame retardant
• External electric cable
• Ingredients containing radioactive substances
•  Electrolytic capacitors containing substances of con-
cern (height ≥25 mm, diameter ≥25 mm)
• Beryllium (bending magnet beam exit window)
•  Radiation shielding lead (bending magnet, collimator, 
carousel) and lead solder
• Metal surfaces, sheet metal, and hardware surfaces
2.  Status of linac radioactive waste management 
in Japan
Regulations for the dismantling and disposal of radioac-
tive waste are outlined in the Act on the Regulation of Ra-
dioactive Isotopes (Atomic Energy Regulatory Authority), 















Fig. 5. Medical linear accelator (linac) disassembly and disassembly procedure. IM, Interface Mount; MLC, multileaf collimator.
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of Health, Labor, and Welfare), the Labor Safety and Sani-
tation Act, and the Radio Law (Ministry of Internal Affairs 
and Communications). In Japan, regulations and facility 
standards, such as storage, disposal, incineration, and dis-
posal of radioactive waste, are applied in the same manner 
as applied to waste contaminated by radioisotopes [11].
1) Procedure for replacement and abolition 
The procedures followed during the preparation stage 
for replacement of equipment or abolition of the facility is 
shown in Fig. 6. Japan recommends forming a dedicated 
group to replace equipment, as well as an additional re-
view group within an institution that uses a linac. The 
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Fig. 6. Linear accelator (linac) dis-
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Fig. 7. Process of reuse and disposal of radioactive waste for radiation therapy device. Linac, linear accelator; RI, radiation isotope.
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facility and conducts an overall estimate of the work to be 
performed and the cost. Next, a procedure for finalizing a 
disposal plan should be created by making decisions on 
institutional policies, the division of roles, scheduling, and 
budget.
When replacing or disposing of equipment, the user 
should classify and dismantle the radioactive components 
(regulated parts). In addition, the components are divided 
into those that can be reused and those to be disposed of, 
as shown in Fig. 7. Equipment to be reused is transported 
to a licensed user at another facility. Transportation imme-
diately after dismantling or storage in a radioactive waste 
storage facility are optional. Equipment to be discarded is 
either immediately disposed of without first storing it in a 
storage disposal facility or it is stored similarly to equip-
ment that is reused.
2) Measurement procedure for activation
The procedure for radiation measurement during disas-
sembly of a linac is shown in Fig. 8. Radiation measure-
ments related to the handling of radioactive waste should 
be conducted when disposing of regulated activation 
products, for products to be taken out of the radiation-con-
trolled area, and for transport. The dose rate is measured at 
a distance of 1 cm from the equipment part by using a sur-
vey meter and the dose rate is converted into Bq according 
to the conversion table used in Japan. After determining 
the reference dose of the radionuclides, the components 
are divided and stored in a drum.
In addition, if storage and disposal facilities are installed, 
periodic dose measurements are required. The types of 
measurements are divided into cases that the medical in-
stitution directly conducts and cases that are entrusted to 
a professional contractor. In addition, the final evaluation 
should be conducted by the medical institution even in the 
case of consignment.
3.  Status of linac radioactive waste management 
in Europe
The European Commission provides recommendations 
on the “Practical use of the concepts of clearance and 
exemption” in accordance with the Radiation Protection 
Report 122 as published in 2000 [12]. In principle, waste 
should not be generated and resources should be reused; 
however, radioactive materials are classified as exceptions 
and disposal is recommended.
In the case of radioactive waste, it is not necessary to re-
port radioactive material with an activity concentration be-
low the specific exemption for nuclides and prior approval 
for disposal is not required. The standard for clearance of 
radioactive waste is 10 μSv/y for individuals and 1 man-Sv/y 
for collective doses. The standards for clearance follow the 
IAEA Safety Series 89, but the Commission has difficulty 
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Fig. 8. Measurement and disposal of radioactive waste for medical 
linear accelerator (linac). RI, radiation isotope.
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individual exposure. Therefore, exposure scenarios are 
typically constructed to obtain individual doses [13].
1) Linac disposal management in Germany
Germany’s Radiation Protection Committee recom-
mends clearance criteria for accelerators based on a 
report, “Clearance of accelerators and the removal of ac-
celerator parts from radiation protection areas,” which was 
published in 2009 [14]. Dismantling and disposal should 
be performed based on the history of an accelerator, op-
erating time, and component materials. In particular, the 
establishment of a disposal standard for an accelerator is 
proposed by considering the nuclides of each component. 
However, as in Korea, no clear procedures and regulations 
exist, but these will be considered in the next revision of 
the radiation protection regulations.
In accordance with the treaty (2016/C 203/01) published 
in 2016 by the European Atomic Energy Community (Eura-
tom), European Union (EU) countries, such as Germany, 
Sweden, the United Kingdom, and France, have prepared 
disposal plan reports for when radioactive waste is gener-
ated [15]. Each member state must provide the European 
Committee with a radioactive waste disposal plan and de-
termine whether the implementation of the plan could re-
sult in water, soil, or radioactive contamination. The reports 
must include information about the facility from which the 
waste originated, the distance to the EU member state clos-
est to the facility, whether the waste is stored prior to trans-
portation, and whether it is within the dose limits [16].
4.  Status of linac radioactive waste management 
in Canada
In Canada, to dismantle a facility where a medical linac 
is used, a permit application is first submitted, as well as a 
plan of action. As shown in Table 2, a final decommission-
ing report, including a decommissioning plan, information 
on generated radioactive materials, preparation for dispos-
al of other hazardous substances, and other factors, should 
be prepared and submitted to the Canadian Nuclear Safety 
Commission (CNSC). At this time, Class II equipment is 
regulated as follows:
•  Particle accelerators with beam energy of less than 50 
MeV that are capable of producing nuclear energy
• Irradiators using nuclear material of 1,015 Bq or higher
•  Irradiators requiring shielding because the dose rate at 
1 m exceeds 1 cGy/min
•  External treatment devices or remote brachytherapy 
devices (afterloaders) using a radioactive source
1) Disposal method in Canada
Canada disposes of parts differently depending on the 
Table 2. Content of final medical linear accelerator dismantling report in Canada
Outline of the decommissioning 
plan
Decommissioning schedule
Information on structures, components, systems, equipment, nuclear materials, and land that will be 
affected by the dismantling
Problems that may arise from dismantling and proper measures
Whether pollutants, radioactive products, or other harmful substances remain after dismantling
Manpower qualification and 
training
Name and title of the person responsible for decommissioning plan
Qualifications and training requirements of workers
Dismantling of external facilities: name and information of the relevant institution, regardless of 
whether safety education has been completed
Accelerator disassembly requires a license for Class II regulated equipment
Estimation of the type, activity, 
and radiation dose of nuclear 
materials
The properties, types, and radioactivity of radioactive materials or contamination information of the 
nuclear facility
Products and components expected to be radioactive upon dismantling 
Estimates of radioactivity
Estimated maximum dose rates and doses that a person can be exposed to as a result of dismantling
Disposal of Class II regulated 
equipment, nuclear and 
hazardous materials
Proposed final disposal method for the major components of the accelerator (e.g., sale or disposal, 
return to the manufacturer, transfer to another facility for potential reuse, or kept by the license 
holder for future reuse)
Transfer to another institution: recipient’s name and contact information
Information on whether material is released into the environment and the maximum amount and 
concentration of nuclear and hazardous substances that can be released
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level of activation of products from medical linacs and the 
possession of a CNSC license. In the case of a permitted fa-
cility with a CNSC license, the linac is returned to its manu-
facturer. If the facility has no license, the accelerator or its 
components are transferred to a repair company. Except 
for the above examples, waste is typically disposed accord-
ing to clearance criteria. 
Other than for a return to the manufacturer (in the case 
of a transfer to a repair company) or when using general 
waste disposal methods, the requirements of section 5.1 of 
the Nuclear Substances and Radiation Device Regulations 
must be satisfied [17]. In the absence of a license, a linac 
can be disposed of if the radioactivity or concentration 
of radioactive nuclear material does not exceed standard 
guidelines. In Canada, a dose rate-based measurement 
method is recommended. In the case of medical accelera-
tors, conditional clearance is allowed if the measurement 
is less than 0.5 μSv/h when measured at 5 cm from the ac-
cessible surface of the component [18].
5.  Radioactive waste management and comparison 
of clearance level
1) Comparison of storage management of radioactive 
waste
After disassembly of the linac, the classified radioactive 
parts must be stored in a storage box that conforms to a 
certain standard or disposed of after storage. In countries 
that recommend storage boxes for storing radioactive 
waste and linac parts, we classified the standards of Japan’s 
Society Standard Technical Reports and reports from Var-
ian Co., as shown in Table 3 [11]. The basic standard is 50 
L in Japan and 210 L in the United States. In Japan, an ap-
plication is submitted to borrow a waste storage container. 
A 50 L drum can be borrowed for free and 210 L drums 
are rented for a fee. At this time, four 50-L drums are typi-
cally used. In the United States, 55 gallon (210 L) drums 
and the insertion of foam are required for the storage and 
management of radioactive parts. It is recommended that 
Table 3. Comparison of medical linac radioactive waste storage containers
Country Japan USA
Standard 50 L
Inner diameter and height: 33 cm, 55 cm
Less than 60 kg per container
210 L (55 gallons)
Other information Fill out the application for borrowing of waste containers
Typically, four 50-L drums are required
Free rental of 50 L drums
If the parts are large, 200 L drum is used, but container  
fee and container shipping fee are charged
210 L drum and inserted foam are required as standard 
for storage and maintenance of radioactive components
For storage of other parts, capacitors, etc.: three 19-L 
steel drums
Two plastic tarpaulins for floor protection and 
contaminated dust collection
Wooden pallet
Table 4. Criteria for evaluation and clearance of radioactive waste in the linac
Country Japan USA Canada
Measuring 
instrument
NaI(Tl) scintillation survey meter NaI(Tl) scintillation survey meter, Geiger–




1 cm distance 1 cm distance 5 cm distance
Clearance 
criteria
10 μSv/y 10 μSv/y (1 mrem/y) 0.5 μSv/h (10 μSv/y)
Other Calculate the amount of radioactivity 
(Bq) based on the dose rate (μSv/h) 
measured (weight measurement and 
conversion factor applied)
Effective distance of scintillator 
instrument: 1 cm from the surface
[SLAC Accelerator] When metal/concrete 
is irradiated at a volume radiation level 
of 1 pCi/g → ~1 mrem/h at a distance of 
2 cm from the surface
When converting to the effective dose, 
use the 30 cm standard (distance 
inverse square law)
Calculated assuming an average 
working time of 40 hours and that 15 
linac parts are managed per year
SLAC, Stanford Linear Accelerator Center.
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three 5-gallon (19 L) steel drums are used for other parts 
and that two plastic tarps are used to protect the floor and 
collect contaminated dust. Wooden pallets can be used if 
necessary.
2) Comparison of radioactive waste disposal standards 
and radioactive evaluation methods of medical linacs
The clearance criteria for radioactive waste from the 
medical linac and the method of evaluating the activation 
differ, as shown in Table 4. As a detector for evaluating ra-
dioactive waste, Japan, the United States, and Canada typi-
cally use a survey meter. The location of the measurement 
is at a distance of 1 cm in Japan and the United States, but 
5 cm in Canada. The clearance criterion is 10 μSv/y in all 
three countries, which is the same as in Korea. Canada al-
lows a clearance of 0.5 μSv/h or less. This is a calculated 
value assuming that the annual allowance standard is an 
average working time of 40 hours and that 15 linac parts 
are managed per year.
Conclusions
In this study, to establish safety regulation guidelines and 
procedures for the management of radioactive waste from 
medical linacs in Korea, the current management practices 
in Korea and abroad were investigated.
As a result of this investigation, it was shown that stan-
dards and procedures for disposing of a linac have yet to be 
established in Korea. Because activated waste generated 
by a medical linac is not classified as radioactive waste, the 
Korean radioactive waste agency, a facility that disposes 
and manages waste, handles only radioisotopes.
Because no legally prescribed procedure or standard for 
disposing of a linac exists, it was found that most medical 
institutions do not have safety management regulations. 
In addition, radioactive waste is collected by companies 
without following any procedures or guidelines or the head 
of medical linacs are stored in the waste storage areas at 
hospitals. It was shown that the institutions or individual 
owners in Korea collect the waste by using a company but 
without any action taken at medical institutions.
Japan, the United States, and Canada have guidelines to 
treat radioactive waste that is produced by a linac. Japan 
has regulated radioactive cargo from linacs in the same 
way that radioactive isotopes are regulated, and the United 
States and Canada have proposed clearance criteria for 
radioactive waste. However, most reports from the EU, the 
International Atomic Energy Agency, and the United States 
have provided management guidelines for research or 
large-scale accelerators, but not for linacs.
For the safe management of a medical linac, it is neces-
sary to establish safety management regulations for radio-
active waste produced at medical institutions.
First, before dismantling the linac, a dismantling and 
disposal plan must be prepared and reported to the KINS 
as recommended by European nations, such as Germany. 
In addition, medical institutions should form a dedicated 
team that will perform the work, as is done to Japan. For 
the process of disposal, as suggested by the processes per-
formed Japan, the United States, and Canada, the dose rate 
of the components is measured using a survey meter and 
the general and radioactive waste should be classified ac-
cording to the 0.5 μSv/h standard. In addition, the sorted 
parts must be stored or transported in standardized drums 
50 or 210 L in size. 
In Korea, standards for disposal, such as dose limits, are 
required for medical linacs. As in other countries, a system 
for the disposal of a linac according to a clear procedure 
should be established.
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